FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
Craig-Hallum downgraded RTI Biologics (NASDAQ: RTIX) from Buy to Hold with a price target of $4.00 (from $6.00).
For an analyst ratings summary and ratings history on RTI Biologics click here. For more ratings news on RTI Biologics click here.
Shares of RTI Biologics closed at $3.43 yesterday.
... More
